Header Logo

Connection

DAVID STEFFIN to Recurrence

Back to Details
This is a "connection" page, showing publications DAVID STEFFIN has written about Recurrence.
DAVID STEFFIN
Connection Strength
0.040
Recurrence
  1. Blinatumomab Therapy Is Associated with Favorable Outcomes after Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients with B Cell Acute Lymphoblastic Leukemia. Transplant Cell Ther. 2024 02; 30(2):217-227.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.